Impact of PRECISE-DAPT and DAPT Scores on Dual Antiplatelet Therapy Duration After 2nd Generation Drug-Eluting Stent Implantation
Author(s) -
Ji-Yong Jang,
Hae Won Jung,
Byoung Kwon Lee,
DongHo Shin,
JungSun Kim,
SungJin Hong,
ChulMin Ahn,
ByeongKeuk Kim,
YoungGuk Ko,
Donghoon Choi,
MyeongKi Hong,
Kyung Woo Park,
HyeonCheol Gwon,
HyoSoo Kim,
Hyuck Moon Kwon,
Yangsoo Jang
Publication year - 2020
Publication title -
cardiovascular drugs and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 69
eISSN - 1573-7241
pISSN - 0920-3206
DOI - 10.1007/s10557-020-07008-7
Subject(s) - medicine , drug eluting stent , stent , randomized controlled trial , cardiology , clinical trial , surgery , restenosis
Determining the optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is an important clinical issue. We evaluated the effects of ischemia (by DAPT score) and bleeding (by PRECISE-DAPT score), as well as the impact of DAPT duration, on clinical outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom